Then & Now
Join Worldwide’s own Sherilyn Adcock, EVP of Medical and Scientific Affairs, as she discusses industry changes in Phase 1 Early development programs over recent years.
- Shifts in formal drug testing and approval processes
- Combining of single and multiple ascending dose studies
- Advanced statistical methodology
HOW WELL DO YOU KNOW WORLDWIDE CLINICAL TRIALS?
You’ve probably heard about Worldwide’s full-service, award-winning CRO services spanning Bioanalytical, Phase I-IV clinical trial, and Real-World Evidence. And most people know that our therapeutic expertise is focused on Central Nervous System, Cardiovascular and Metabolic, Oncology, Rare Diseases, or General Medicine.
Yet, there might be a few things about Worldwide you don’t know.
We live and breathe to be UNCOMMON, and it all starts with innovation. Every clinical trial is unique and deserves an uncommon, innovative approach deeply rooted in a commitment to operational excellence. That’s why we are creating uncommon events to connect executives with their industry peers to generate ideas, exchange insights and discuss inventive new strategies to overcome clinical trial obstacles. Advancing medicine to improve the lives of patients around the world is our passion, and we believe when you bring together biopharma’s top minds, magic happens.